PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

L2FU Releases its First Guide to Effective Management of Patients Lost to Follow Up in Clinical Trials

Comprehensive guide filled with tips for minimizing patient lost to follow up -a free tool for study sponsors, clinical trial sites and academic research centers.
Philadelphia, USA | London, England, June 16, 2015 – FOR IMMEDIATE RELEASE
L2FU® (Lost to Follow Up), a global leader specializing in locating clinical trial patients lost to follow up, has just released its newly published guide; “Maintaining Clinical Trial Integrity & Minimizing Missing Data: The Official Guide To Lost To Follow Up Management.” The booklet is a resource for study sponsors, research centers and hospitals.
The 24-page guide features tips for securing accurate patient contact info and staying on top of changes; identifying at-risk patients promptly by noting such red flags as missing a visit, lacking reliable transportation or experiencing employment or financial problems; and locating lost to follow up patients via a proven five-step process. The booklet also features unique insights from the L2FU team based on their years of experience and 90 percent success rate locating patients lost to follow up. In addition to covering proven methods for lost to follow up patient management, the guide also includes background on L2FU’s experience optimizing clinical trials by reducing the number of patients lost to follow up—and the important data they represent.
“This best practice guide reflects more than a decade of experience and hard work,” says Hema Gadhia, Senior Operations Support Manager at L2FU. “We hope others can benefit from what we’ve learned locating patients in more than 60 countries. The booklet includes an overview on the impact of patients lost to follow up and detailed steps for locating those patients quickly. It is five times more costly to recruit a new patient than it is to retain one, so these guidelines can truly help sponsors save money, meet timelines and maintain data integrity.”
To request your free copy, visit L2FU.net today and click “download the booklet” at the top of the page.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026